COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB James L. Alexander , Nick Kennedy , Hajir Ibraheim , Sulak Anandabaskaran , Aamir Saifuddin , Rocio Castro Seoane , Zhigang Liu , Rachel Nice , Claire M. Bewshea , Andrea D'Mello , Laura E. Constable , Gareth-Rhys Jones , Sharmili Balarajah , Francesca Fiorentino , Shaji Sebastian , Peter M. Irving , Lucy C. Hicks , Horace R. Williams , Alexandra J. Kent , Miles Parkes , Klaartje Kok , Kamal V. Patel , Daniel Altmann , Rosemary Boyton , James Goodhand , Ailsa Hart , Charlie W. Lees , Tariq Ahmad , Nick Powell Social Science Research Network(2022)
AI 理解论文
溯源树
样例